{"id":4025,"date":"2026-10-23T13:02:25","date_gmt":"2026-10-23T11:02:25","guid":{"rendered":"https:\/\/medicontrol.it\/breakthrough-ptsd-treatment-achieves-68-remission-rate-in-clinical-trial\/"},"modified":"2026-10-23T13:02:25","modified_gmt":"2026-10-23T11:02:25","slug":"breakthrough-ptsd-treatment-achieves-68-remission-rate-in-clinical-trial","status":"publish","type":"post","link":"https:\/\/medicontrol.it\/en\/breakthrough-ptsd-treatment-achieves-68-remission-rate-in-clinical-trial\/","title":{"rendered":"Breakthrough PTSD treatment achieves 68% remission rate in clinical trial"},"content":{"rendered":"<p>A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical&hellip;\u00a0<a href=\"https:\/\/www.sciencedaily.com\/releases\/2026\/10\/261022081309.htm\" target=\"_blank\" class=\"feedzy-rss-link-icon\">Read More<\/a>\u200b\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.<\/p>","protected":false},"author":2,"featured_media":130,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_templately_pack_id":"","_templately_imported_at":"","_templately_source":"","_templately_import_session_id":"","footnotes":""},"categories":[],"tags":[],"class_list":["post-4025","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"jetpack_featured_media_url":"https:\/\/medicontrol.it\/wp-content\/uploads\/2025\/09\/cropped-10.png","_links":{"self":[{"href":"https:\/\/medicontrol.it\/en\/wp-json\/wp\/v2\/posts\/4025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicontrol.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicontrol.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicontrol.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicontrol.it\/en\/wp-json\/wp\/v2\/comments?post=4025"}],"version-history":[{"count":0,"href":"https:\/\/medicontrol.it\/en\/wp-json\/wp\/v2\/posts\/4025\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicontrol.it\/en\/wp-json\/wp\/v2\/media\/130"}],"wp:attachment":[{"href":"https:\/\/medicontrol.it\/en\/wp-json\/wp\/v2\/media?parent=4025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicontrol.it\/en\/wp-json\/wp\/v2\/categories?post=4025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicontrol.it\/en\/wp-json\/wp\/v2\/tags?post=4025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}